SXTP Stock Summary and Trading Ideas (60 Degrees Pharmaceuticals | NASDAQ:SXTP)

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

60 Degrees Pharmaceuticals trades on the NASDAQ stock market under the symbol SXTP.

As of August 28, 2026, SXTP stock price declined to $1.03 with 18,569 million shares trading.

SXTP has a beta of 1.59, meaning it tends to be more sensitive to market movements. SXTP has a correlation of 0.03 to the broad based SPY ETF.

SXTP has a market cap of $3.62 million. This is considered a Sub-Micro Cap stock.

Last quarter 60 Degrees Pharmaceuticals reported $56,798 in Revenue and -$.90 earnings per share. This fell short of revenue expectation by $-129,202 and missed earnings estimates by -$.04.

In the last 3 years, SXTP traded as high as $369.60 and as low as $1.01.

SXTP has underperformed the market in the last year with a price return of -80.2% while the SPY ETF gained +19.7%. SXTP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.9% and -13.8%, respectively, while the SPY returned +2.2% and -0.9%, respectively.

SXTP support price is $.98 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SXTP shares will trade within this expected range on the day.